Surgery following chemotherapy for metastatic testicular teratoma. 1991

D Whillis, and R E Coleman, and A M Lessells, and T B Hargreave, and M A Cornbleet, and G C Howard
Department of Clinical Oncology, Western General Hospital, Edinburgh.

Twenty patients with metastatic testicular teratoma underwent surgery for residual disease after chemotherapy. Twelve patients in whom complete excision of all residual masses was possible are alive with no evidence of disease. Four patients have died of malignant teratoma, 2 have active malignant disease and 2 have inoperable residual cystic disease. Patients with malignant teratoma intermediate (MTI) primary testis tumours, and those with bulky abdominal disease at presentation, are more likely to have residual masses requiring excision. Completeness of excision appears to be the most important predictor of disease-free survival.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009362 Neoplasm Metastasis The transfer of a neoplasm from one organ or part of the body to another remote from the primary site. Metastase,Metastasis,Metastases, Neoplasm,Metastasis, Neoplasm,Neoplasm Metastases,Metastases
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000971 Antineoplastic Combined Chemotherapy Protocols The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form. Anticancer Drug Combinations,Antineoplastic Agents, Combined,Antineoplastic Chemotherapy Protocols,Antineoplastic Drug Combinations,Cancer Chemotherapy Protocols,Chemotherapy Protocols, Antineoplastic,Drug Combinations, Antineoplastic,Antineoplastic Combined Chemotherapy Regimens,Combined Antineoplastic Agents,Agent, Combined Antineoplastic,Agents, Combined Antineoplastic,Anticancer Drug Combination,Antineoplastic Agent, Combined,Antineoplastic Chemotherapy Protocol,Antineoplastic Drug Combination,Cancer Chemotherapy Protocol,Chemotherapy Protocol, Antineoplastic,Chemotherapy Protocol, Cancer,Chemotherapy Protocols, Cancer,Combinations, Antineoplastic Drug,Combined Antineoplastic Agent,Drug Combination, Anticancer,Drug Combination, Antineoplastic,Drug Combinations, Anticancer,Protocol, Antineoplastic Chemotherapy,Protocol, Cancer Chemotherapy,Protocols, Antineoplastic Chemotherapy,Protocols, Cancer Chemotherapy
D013724 Teratoma A true neoplasm composed of a number of different types of tissue, none of which is native to the area in which it occurs. It is composed of tissues that are derived from three germinal layers, the endoderm, mesoderm, and ectoderm. They are classified histologically as mature (benign) or immature (malignant). (From DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1642) Dysembryoma,Teratoid Tumor,Teratoma, Cystic,Teratoma, Mature,Teratoma, Benign,Teratoma, Immature,Teratoma, Malignant,Benign Teratoma,Benign Teratomas,Dysembryomas,Immature Teratoma,Immature Teratomas,Malignant Teratoma,Malignant Teratomas,Teratoid Tumors,Teratomas,Teratomas, Benign,Teratomas, Immature,Teratomas, Malignant,Tumor, Teratoid,Tumors, Teratoid

Related Publications

D Whillis, and R E Coleman, and A M Lessells, and T B Hargreave, and M A Cornbleet, and G C Howard
June 1987, British journal of urology,
D Whillis, and R E Coleman, and A M Lessells, and T B Hargreave, and M A Cornbleet, and G C Howard
May 1993, Annals of oncology : official journal of the European Society for Medical Oncology,
D Whillis, and R E Coleman, and A M Lessells, and T B Hargreave, and M A Cornbleet, and G C Howard
October 1987, British medical journal (Clinical research ed.),
D Whillis, and R E Coleman, and A M Lessells, and T B Hargreave, and M A Cornbleet, and G C Howard
October 2020, American journal of clinical oncology,
D Whillis, and R E Coleman, and A M Lessells, and T B Hargreave, and M A Cornbleet, and G C Howard
June 1993, Archives of pathology & laboratory medicine,
D Whillis, and R E Coleman, and A M Lessells, and T B Hargreave, and M A Cornbleet, and G C Howard
November 1991, Clinical oncology (Royal College of Radiologists (Great Britain)),
D Whillis, and R E Coleman, and A M Lessells, and T B Hargreave, and M A Cornbleet, and G C Howard
June 1985, Zeitschrift fur Urologie und Nephrologie,
D Whillis, and R E Coleman, and A M Lessells, and T B Hargreave, and M A Cornbleet, and G C Howard
August 1988, The British journal of radiology,
D Whillis, and R E Coleman, and A M Lessells, and T B Hargreave, and M A Cornbleet, and G C Howard
November 1982, European journal of cancer & clinical oncology,
D Whillis, and R E Coleman, and A M Lessells, and T B Hargreave, and M A Cornbleet, and G C Howard
January 1991, European journal of cancer (Oxford, England : 1990),
Copied contents to your clipboard!